This study, called the BLASTT Registry, is observing patients at MD Anderson who have lung cancer or cancer that has spread to their lungs (metastases). These patients are undergoing a procedure called robotic assisted bronchoscopic ablation, which uses a special tool inserted through the windpipe (bronchoscopy) to remove small tumors. The main goal is to collect and analyze information about these patients to better understand the procedure's safety and how well it works to control the cancer. Researchers will look at things like how long patients live without their cancer growing and their overall survival. You may be able to join if you are 18 or older and have peripheral lung tumors that have been or will be treated with this robotic bronchoscopy ablation.

Study design

This is an observational study, meaning researchers will collect information from 250 patients who are already receiving treatment. It is not a randomized study where participants are assigned to different treatment groups.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Researchers will collect data and follow patients through study completion, which is an average of 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.